HEADER DE NOVO PROTEIN 26-JAN-24 8VT8 TITLE UIC-13-BIF-A4DAB NBD-CL BINDING COMPND MOL_ID: 1; COMPND 2 MOLECULE: UIC-13-BIF-A4DAB-NBD-CL; COMPND 3 CHAIN: A, B, C, D; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 4 ORGANISM_TAXID: 32630 KEYWDS SYNTHETIC CONSTRUCT, DE NOVO PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR P.GANATRA REVDAT 3 04-SEP-24 8VT8 1 JRNL REVDAT 2 14-AUG-24 8VT8 1 JRNL REVDAT 1 07-AUG-24 8VT8 0 JRNL AUTH P.GANATRA,D.F.WANG,V.GANATRA,V.T.DANG,A.I.NGUYEN JRNL TITL DIVERSE PROTEOMIMETIC FRAMEWORKS VIA RATIONAL DESIGN OF JRNL TITL 2 PI-STACKING PEPTIDE TECTONS. JRNL REF J.AM.CHEM.SOC. V. 146 22236 2024 JRNL REFN ESSN 1520-5126 JRNL PMID 39096501 JRNL DOI 10.1021/JACS.4C03094 REMARK 2 REMARK 2 RESOLUTION. 1.53 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.53 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.44 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 6463 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.060 REMARK 3 FREE R VALUE TEST SET COUNT : 1207 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 22.4400 - 3.1800 0.98 1207 135 0.1203 0.1874 REMARK 3 2 3.1800 - 2.5300 0.99 1230 134 0.1555 0.1860 REMARK 3 3 2.5200 - 2.2100 0.99 1226 138 0.1719 0.1823 REMARK 3 4 2.2100 - 2.0000 0.99 1231 139 0.1923 0.2324 REMARK 3 5 2.0000 - 1.8600 0.99 1218 134 0.2417 0.2419 REMARK 3 6 1.8600 - 1.7500 1.00 1235 137 0.2778 0.3156 REMARK 3 7 1.7500 - 1.6600 1.00 1236 136 0.3518 0.3601 REMARK 3 8 1.6600 - 1.5900 0.97 1157 131 0.4249 0.4659 REMARK 3 9 1.5900 - 1.5300 0.84 1053 123 0.4398 0.4539 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.309 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 34.938 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.65 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 520 REMARK 3 ANGLE : 1.606 737 REMARK 3 CHIRALITY : 0.046 41 REMARK 3 PLANARITY : 0.007 83 REMARK 3 DIHEDRAL : 32.471 98 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8VT8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-JAN-24. REMARK 100 THE DEPOSITION ID IS D_1000281152. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-FEB-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.729260 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6463 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.530 REMARK 200 RESOLUTION RANGE LOW (A) : 22.440 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.0400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.53 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.59 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 31.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.81 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: ACETONITRILE, WATER, SLOW COOLING, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 9.41800 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 203 DISTANCE = 5.81 ANGSTROMS DBREF 8VT8 A 1 15 PDB 8VT8 8VT8 1 15 DBREF 8VT8 B 1 15 PDB 8VT8 8VT8 1 15 DBREF 8VT8 C 1 15 PDB 8VT8 8VT8 1 15 DBREF 8VT8 D 1 15 PDB 8VT8 8VT8 1 15 SEQRES 1 A 15 Z7Z ALA AIB DAB AIB LEU AIB ALA AIB LEU AIB GLN AIB SEQRES 2 A 15 LEU I77 SEQRES 1 B 15 Z7Z ALA AIB DAB AIB LEU AIB ALA AIB LEU AIB GLN AIB SEQRES 2 B 15 LEU I77 SEQRES 1 C 15 Z7Z ALA AIB DAB AIB LEU AIB ALA AIB LEU AIB GLN AIB SEQRES 2 C 15 LEU I77 SEQRES 1 D 15 Z7Z ALA AIB DAB AIB LEU AIB ALA AIB LEU AIB GLN AIB SEQRES 2 D 15 LEU I77 HET Z7Z A 1 23 HET AIB A 3 13 HET DAB A 4 13 HET AIB A 5 13 HET AIB A 7 13 HET AIB A 9 13 HET AIB A 11 13 HET AIB A 13 13 HET I77 A 15 29 HET Z7Z B 1 23 HET AIB B 3 13 HET DAB B 4 13 HET AIB B 5 13 HET AIB B 7 13 HET AIB B 9 13 HET AIB B 11 13 HET AIB B 13 13 HET I77 B 15 29 HET Z7Z C 1 23 HET AIB C 3 13 HET DAB C 4 14 HET AIB C 5 13 HET AIB C 7 13 HET AIB C 9 13 HET AIB C 11 13 HET AIB C 13 13 HET I77 C 15 29 HET Z7Z D 1 23 HET AIB D 3 13 HET DAB D 4 14 HET AIB D 5 13 HET AIB D 7 13 HET AIB D 9 13 HET AIB D 11 13 HET AIB D 13 13 HET I77 D 15 29 HET 5Z8 A 101 14 HET 5Z8 B 101 14 HET CCN B 102 6 HET CCN D 101 6 HETNAM Z7Z BIPHENYL-4-CARBOXYLIC ACID HETNAM AIB ALPHA-AMINOISOBUTYRIC ACID HETNAM DAB 2,4-DIAMINOBUTYRIC ACID HETNAM I77 5'-(HYDRAZINECARBONYL)[2,2'-BIPYRIDINE]-5-CARBOXAMIDE HETNAM 5Z8 4-CHLORO-7-NITROBENZOFURAZAN HETNAM CCN ACETONITRILE HETSYN 5Z8 4-CHLORANYL-7-NITRO-2,1,3-BENZOXADIAZOLE; NBD-CL; 4- HETSYN 2 5Z8 NITRO-2,1,3-BENZOXADIAZOLE (POST-REACTION) FORMUL 1 Z7Z 4(C13 H10 O2) FORMUL 1 AIB 24(C4 H9 N O2) FORMUL 1 DAB 4(C4 H10 N2 O2) FORMUL 1 I77 4(C12 H11 N5 O2) FORMUL 5 5Z8 2(C6 H2 CL N3 O3) FORMUL 7 CCN 2(C2 H3 N) FORMUL 9 HOH *9(H2 O) HELIX 1 AA1 ALA A 2 LEU A 14 1 13 HELIX 2 AA2 AIB B 3 LEU B 14 1 12 HELIX 3 AA3 AIB C 3 LEU C 14 1 12 HELIX 4 AA4 AIB D 3 LEU D 14 1 12 LINK C1 Z7Z A 1 N ALA A 2 1555 1555 1.43 LINK C ALA A 2 N AIB A 3 1555 1555 1.32 LINK C AIB A 3 N DAB A 4 1555 1555 1.33 LINK C DAB A 4 N AIB A 5 1555 1555 1.32 LINK ND DAB A 4 C3 5Z8 A 101 1555 1555 1.43 LINK C AIB A 5 N LEU A 6 1555 1555 1.33 LINK C LEU A 6 N AIB A 7 1555 1555 1.32 LINK C AIB A 7 N ALA A 8 1555 1555 1.33 LINK C ALA A 8 N AIB A 9 1555 1555 1.33 LINK C AIB A 9 N LEU A 10 1555 1555 1.32 LINK C LEU A 10 N AIB A 11 1555 1555 1.33 LINK C AIB A 11 N AGLN A 12 1555 1555 1.33 LINK C AIB A 11 N BGLN A 12 1555 1555 1.33 LINK C AGLN A 12 N AIB A 13 1555 1555 1.33 LINK C BGLN A 12 N AIB A 13 1555 1555 1.33 LINK C AIB A 13 N LEU A 14 1555 1555 1.32 LINK C LEU A 14 N15 I77 A 15 1555 1555 1.43 LINK C1 Z7Z B 1 N ALA B 2 1555 1555 1.42 LINK C ALA B 2 N AIB B 3 1555 1555 1.33 LINK C AIB B 3 N DAB B 4 1555 1555 1.33 LINK C DAB B 4 N AIB B 5 1555 1555 1.33 LINK ND DAB B 4 C3 5Z8 B 101 1555 1555 1.43 LINK C AIB B 5 N LEU B 6 1555 1555 1.33 LINK C LEU B 6 N AIB B 7 1555 1555 1.33 LINK C AIB B 7 N ALA B 8 1555 1555 1.33 LINK C ALA B 8 N AIB B 9 1555 1555 1.33 LINK C AIB B 9 N LEU B 10 1555 1555 1.33 LINK C LEU B 10 N AIB B 11 1555 1555 1.33 LINK C AIB B 11 N GLN B 12 1555 1555 1.34 LINK C GLN B 12 N AIB B 13 1555 1555 1.33 LINK C AIB B 13 N LEU B 14 1555 1555 1.33 LINK C LEU B 14 N15 I77 B 15 1555 1555 1.42 LINK C1 Z7Z C 1 N ALA C 2 1555 1555 1.43 LINK C ALA C 2 N AIB C 3 1555 1555 1.33 LINK C AIB C 3 N DAB C 4 1555 1555 1.32 LINK C DAB C 4 N AIB C 5 1555 1555 1.33 LINK C AIB C 5 N LEU C 6 1555 1555 1.33 LINK C LEU C 6 N AIB C 7 1555 1555 1.32 LINK C AIB C 7 N ALA C 8 1555 1555 1.33 LINK C ALA C 8 N AIB C 9 1555 1555 1.33 LINK C AIB C 9 N LEU C 10 1555 1555 1.33 LINK C LEU C 10 N AIB C 11 1555 1555 1.33 LINK C AIB C 11 N GLN C 12 1555 1555 1.32 LINK C GLN C 12 N AIB C 13 1555 1555 1.32 LINK C AIB C 13 N LEU C 14 1555 1555 1.34 LINK C LEU C 14 N15 I77 C 15 1555 1555 1.44 LINK C1 Z7Z D 1 N ALA D 2 1555 1555 1.43 LINK C ALA D 2 N AIB D 3 1555 1555 1.32 LINK C AIB D 3 N DAB D 4 1555 1555 1.32 LINK C DAB D 4 N AIB D 5 1555 1555 1.32 LINK C AIB D 5 N LEU D 6 1555 1555 1.32 LINK C LEU D 6 N AIB D 7 1555 1555 1.33 LINK C AIB D 7 N ALA D 8 1555 1555 1.33 LINK C ALA D 8 N AIB D 9 1555 1555 1.32 LINK C AIB D 9 N LEU D 10 1555 1555 1.32 LINK C LEU D 10 N AIB D 11 1555 1555 1.33 LINK C AIB D 11 N GLN D 12 1555 1555 1.33 LINK C GLN D 12 N AIB D 13 1555 1555 1.33 LINK C AIB D 13 N LEU D 14 1555 1555 1.33 LINK C LEU D 14 N15 I77 D 15 1555 1555 1.42 CRYST1 23.753 18.836 47.762 90.00 98.88 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.042100 0.000000 0.006578 0.00000 SCALE2 0.000000 0.053090 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021191 0.00000 HETATM 1 O1 Z7Z A 1 18.549 5.422 6.309 1.00 37.46 O ANISOU 1 O1 Z7Z A 1 4136 4227 5870 933 1286 -510 O HETATM 2 C1 Z7Z A 1 19.729 5.547 5.921 1.00 32.57 C ANISOU 2 C1 Z7Z A 1 3413 3205 5756 1630 651 -18 C HETATM 3 C2 Z7Z A 1 20.833 5.159 6.878 1.00 28.72 C ANISOU 3 C2 Z7Z A 1 3558 1926 5429 603 166 -1007 C HETATM 4 C3 Z7Z A 1 20.493 4.841 8.180 1.00 33.08 C ANISOU 4 C3 Z7Z A 1 4442 2076 6052 582 87 -1130 C HETATM 5 C4 Z7Z A 1 21.468 4.479 9.099 1.00 32.83 C ANISOU 5 C4 Z7Z A 1 4504 2020 5949 219 -262 -1249 C HETATM 6 C5 Z7Z A 1 22.158 5.117 6.493 1.00 32.04 C ANISOU 6 C5 Z7Z A 1 4055 2421 5699 566 88 -1573 C HETATM 7 C6 Z7Z A 1 23.128 4.745 7.418 1.00 32.35 C ANISOU 7 C6 Z7Z A 1 4147 2226 5920 -6 -491 -1472 C HETATM 8 C7 Z7Z A 1 22.792 4.443 8.724 1.00 32.29 C ANISOU 8 C7 Z7Z A 1 4433 1921 5913 83 -304 -1143 C HETATM 9 C8 Z7Z A 1 23.854 4.042 9.757 1.00 38.34 C ANISOU 9 C8 Z7Z A 1 4906 3115 6547 110 30 -1197 C HETATM 10 C9 Z7Z A 1 23.679 4.367 11.092 1.00 38.37 C ANISOU 10 C9 Z7Z A 1 4639 3266 6675 -265 37 -795 C HETATM 11 C10 Z7Z A 1 24.981 3.337 9.384 1.00 38.04 C ANISOU 11 C10 Z7Z A 1 5276 2563 6614 1028 0 -1357 C HETATM 12 C11 Z7Z A 1 24.613 4.007 12.051 1.00 38.98 C ANISOU 12 C11 Z7Z A 1 5029 3084 6698 298 30 -156 C HETATM 13 C12 Z7Z A 1 25.925 2.965 10.340 1.00 38.14 C ANISOU 13 C12 Z7Z A 1 5776 2133 6583 953 -7 -862 C HETATM 14 C13 Z7Z A 1 25.743 3.299 11.675 1.00 36.99 C ANISOU 14 C13 Z7Z A 1 5213 2144 6698 939 231 -218 C HETATM 15 H31 Z7Z A 1 19.455 4.874 8.486 1.00 39.71 H HETATM 16 H41 Z7Z A 1 21.187 4.224 10.114 1.00 39.40 H HETATM 17 H51 Z7Z A 1 22.439 5.370 5.479 1.00 38.46 H HETATM 18 H61 Z7Z A 1 24.165 4.692 7.110 1.00 38.83 H HETATM 19 H91 Z7Z A 1 22.794 4.914 11.392 1.00 46.06 H HETATM 20 H101 Z7Z A 1 25.133 3.071 8.345 1.00 45.65 H HETATM 21 H111 Z7Z A 1 24.460 4.278 13.088 1.00 46.78 H HETATM 22 H121 Z7Z A 1 26.806 2.413 10.040 1.00 45.78 H HETATM 23 H131 Z7Z A 1 26.477 3.009 12.416 1.00 44.40 H